Canada Pension Plan Investment Board Has $120,000 Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Canada Pension Plan Investment Board boosted its position in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 18.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 29,300 shares of the company’s stock after purchasing an additional 4,500 shares during the quarter. Canada Pension Plan Investment Board’s holdings in Definitive Healthcare were worth $120,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Hennion & Walsh Asset Management Inc. lifted its holdings in shares of Definitive Healthcare by 34.1% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock valued at $209,000 after purchasing an additional 12,946 shares in the last quarter. Barclays PLC raised its holdings in Definitive Healthcare by 318.8% during the 3rd quarter. Barclays PLC now owns 81,916 shares of the company’s stock worth $366,000 after buying an additional 62,354 shares during the period. JPMorgan Chase & Co. lifted its stake in Definitive Healthcare by 431.7% in the third quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock valued at $993,000 after buying an additional 180,323 shares in the last quarter. State Street Corp boosted its holdings in shares of Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after buying an additional 317,952 shares during the period. Finally, Quantbot Technologies LP increased its position in shares of Definitive Healthcare by 5,305.5% during the fourth quarter. Quantbot Technologies LP now owns 17,730 shares of the company’s stock worth $73,000 after acquiring an additional 17,402 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock opened at $2.71 on Friday. The stock has a market cap of $305.99 million, a P/E ratio of -0.87, a P/E/G ratio of 4.06 and a beta of 1.48. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare Corp. has a 12-month low of $2.15 and a 12-month high of $7.47. The business’s 50 day moving average is $3.02 and its 200-day moving average is $3.98.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The firm had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. Equities research analysts predict that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

DH has been the topic of several research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Barclays cut their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Finally, The Goldman Sachs Group decreased their price objective on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $5.35.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.